250 related articles for article (PubMed ID: 17206620)
1. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
[TBL] [Abstract][Full Text] [Related]
3. Inherited disorders of collagen gene structure and expression.
Byers PH
Am J Med Genet; 1989 Sep; 34(1):72-80. PubMed ID: 2683783
[TBL] [Abstract][Full Text] [Related]
4. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
[TBL] [Abstract][Full Text] [Related]
5. A cysteine for glycine substitution at position 1017 in an alpha 1(I) chain of type I collagen in a patient with mild dominantly inherited osteogenesis imperfecta.
Labhard ME; Wirtz MK; Pope FM; Nicholls AC; Hollister DW
Mol Biol Med; 1988 Dec; 5(3):197-207. PubMed ID: 3244312
[TBL] [Abstract][Full Text] [Related]
6. Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.
Starman BJ; Eyre D; Charbonneau H; Harrylock M; Weis MA; Weiss L; Graham JM; Byers PH
J Clin Invest; 1989 Oct; 84(4):1206-14. PubMed ID: 2794057
[TBL] [Abstract][Full Text] [Related]
7. Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue.
Prockop DJ; Constantinou CD; Dombrowski KE; Hojima Y; Kadler KE; Kuivaniemi H; Tromp G; Vogel BE
Am J Med Genet; 1989 Sep; 34(1):60-7. PubMed ID: 2683782
[TBL] [Abstract][Full Text] [Related]
8. Altered relation of two collagen types in osteogenesis imperfecta.
Sykes B; Francis MJ; Smith R
N Engl J Med; 1977 May; 296(21):1200-3. PubMed ID: 857159
[TBL] [Abstract][Full Text] [Related]
9. Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule.
Lightfoot SJ; Holmes DF; Brass A; Grant ME; Byers PH; Kadler KE
J Biol Chem; 1992 Dec; 267(35):25521-8. PubMed ID: 1460046
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method.
Bateman JF; Hannagan M; Chan D; Cole WG
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):765-70. PubMed ID: 2064612
[TBL] [Abstract][Full Text] [Related]
11. Osteogenesis imperfecta missense mutations in collagen: structural consequences of a glycine to alanine replacement at a highly charged site.
Xiao J; Cheng H; Silva T; Baum J; Brodsky B
Biochemistry; 2011 Dec; 50(50):10771-80. PubMed ID: 22054507
[TBL] [Abstract][Full Text] [Related]
12. Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of osteogenesis imperfecta minimally destabilizes the triple helix of type I procollagen. The effects of glycine substitutions on thermal stability are either position of amino acid specific.
Pack M; Constantinou CD; Kalia K; Nielsen KB; Prockop DJ
J Biol Chem; 1989 Nov; 264(33):19694-9. PubMed ID: 2511192
[TBL] [Abstract][Full Text] [Related]
13. Type II collagen defect in two sibs with the Goldblatt syndrome, a chondrodysplasia with dentinogenesis imperfecta, and joint laxity.
Bonaventure J; Stanescu R; Stanescu V; Allain JC; Muriel MP; Ginisty D; Maroteaux P
Am J Med Genet; 1992 Dec; 44(6):738-53. PubMed ID: 1481841
[TBL] [Abstract][Full Text] [Related]
14. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.
Shapiro JR; Stover ML; Burn VE; McKinstry MB; Burshell AL; Chipman SD; Rowe DW
J Clin Invest; 1992 Feb; 89(2):567-73. PubMed ID: 1737847
[TBL] [Abstract][Full Text] [Related]
15. [Collagen metabolic disorders--Ehlers-Danlos syndrome and osteogenesis imperfecta].
Nagai Y
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):801-4. PubMed ID: 3270895
[No Abstract] [Full Text] [Related]
16. Lethal osteogenesis imperfecta with amniotic band lesions: collagen studies.
van der Rest M; Hayes A; Marie P; Desbarats M; Kaplan P; Glorieux FH
Am J Med Genet; 1986 Jul; 24(3):433-46. PubMed ID: 3728562
[TBL] [Abstract][Full Text] [Related]
17. The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix.
Wenstrup RJ; Shrago-Howe AW; Lever LW; Phillips CL; Byers PH; Cohn DH
J Biol Chem; 1991 Feb; 266(4):2590-4. PubMed ID: 1990009
[TBL] [Abstract][Full Text] [Related]
18. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome.
Vogel A; Holbrook KA; Steinmann B; Gitzelmann R; Byers PH
Lab Invest; 1979 Feb; 40(2):201-6. PubMed ID: 431039
[TBL] [Abstract][Full Text] [Related]
19. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
[TBL] [Abstract][Full Text] [Related]
20. Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity.
Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):131-5. PubMed ID: 1445258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
